Longeveron (LGVN) Gross Margin Growth (1y) (2021 - 2026)
Longeveron (LGVN) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 372.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -5.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -165.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 236.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 | -585.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -585.00 |
| Dec 31, 2025 | -1,748.00 |
| Sep 30, 2025 | 301.00 |
| Jun 30, 2025 | -2,730.00 |
| Mar 31, 2025 | 1,214.00 |
| Dec 31, 2024 | 9,107.00 |
| Sep 30, 2024 | 5,223.00 |
| Jun 30, 2024 | 3,065.00 |
| Mar 31, 2024 | 3,280.00 |
| Dec 31, 2023 | 4,228.00 |
| Sep 30, 2023 | -5,600.00 |
| Jun 30, 2023 | 852.00 |
| Mar 31, 2023 | -2,599.00 |
| Dec 31, 2022 | -7,847.00 |
| Sep 30, 2022 | 2,131.00 |
| Jun 30, 2022 | -820.00 |
| Mar 31, 2022 | 1,360.00 |
| Sep 30, 2021 | 5,069.00 |
| Jun 30, 2021 | 520.00 |
| Mar 31, 2021 | -791.00 |